Genelux (GNLX) Total Liabilities (2022 - 2026)
Genelux's (GNLX) quarterly Total Liabilities came in at $9.5 million in Q1 2026, up 26.3% quarter-over-quarter from $7.5 million in Q4 2025.
Genelux (GNLX) Total Liabilities (2022 - 2026) Analysis & Trends
Genelux's Total Liabilities history runs 5 years deep, the most recent figure standing at $9.5 million for Q1 2026.
- On a quarterly basis, Total Liabilities changed N/A year-over-year to $9.5 million in Q1 2026; TTM through Mar 2026 was $9.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $7.5 million, down 11.36% from the prior year.
- Total Liabilities grew to $9.5 million in Q1 2026 per GNLX's latest filing, from $7.5 million in the prior quarter.
- Across five years, Total Liabilities topped out at $41.3 million in Q4 2022 and bottomed at $6.4 million in Q3 2025.
- The 5-year median for Total Liabilities is $8.4 million (2023), against an average of $11.3 million.
- Across the five-year window, Total Liabilities sank 79.62% in 2023 and rose 11.17% in 2025, its largest moves.
- Year by year, Total Liabilities stood at $41.3 million in 2022, then sank by 79.62% to $8.4 million in 2023, then advanced by 0.26% to $8.4 million in 2024, then decreased by 11.36% to $7.5 million in 2025, then climbed by 26.3% to $9.5 million in 2026.
- Per Business Quant, the three latest GNLX Total Liabilities figures stand at $9.5 million (Q1 2026), $7.5 million (Q4 2025), and $6.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 177.22 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 19.51 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 3.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 753.82 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 9.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.45 Mn |
| Dec 31, 2025 | 7.48 Mn |
| Sep 30, 2025 | 6.40 Mn |
| Jun 30, 2025 | 8.35 Mn |
| Dec 31, 2024 | 8.44 Mn |
| Sep 30, 2024 | 7.18 Mn |
| Jun 30, 2024 | 7.51 Mn |
| Mar 31, 2024 | 9.59 Mn |
| Dec 31, 2023 | 8.42 Mn |
| Sep 30, 2023 | 10.04 Mn |
| Dec 31, 2022 | 41.31 Mn |